0001177648-20-000016.txt : 20200228 0001177648-20-000016.hdr.sgml : 20200228 20200228171418 ACCESSION NUMBER: 0001177648-20-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200226 FILED AS OF DATE: 20200228 DATE AS OF CHANGE: 20200228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peterson Kristine CENTRAL INDEX KEY: 0001508596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35839 FILM NUMBER: 20672159 MAIL ADDRESS: STREET 1: AMARIN CORPORATION STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE CITY: MYSTIC STATE: CT ZIP: 06355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001177648 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617 607 0800 MAIL ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-02-26 0001177648 ENANTA PHARMACEUTICALS INC ENTA 0001508596 Peterson Kristine C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472 1 0 0 0 Stock Option (right to buy) 51.04 2020-02-26 4 A 0 10000 0 A 2030-02-26 Common Stock 10000 10000 D Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 26, 2020), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2021 annual meeting of stockholders. /s/ Nathaniel S. Gardiner as attorney-in-fact 2020-02-28